Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®
NCT01731028 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2013-02-01
Summary
The purpose of this study is to investigate the long-term treatment with Zomacton® for pituitary short stature in children with insufficient growth hormone production and/or short stature caused by Turner's syndrome.
Conditions
- Growth Hormone Deficiency
Interventions
- DRUG
-
Somatropin
Somatropin powder and solvent for solution for injection
Sponsors & Collaborators
-
Ferring Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Clinical Development Support · Ferring Pharmaceuticals
Eligibility
- Min Age
- 3 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2017-12-31
- Completion
- 2018-06-30
More Related Trials
-
A Study of Zomacton in Children With Growth Hormone Deficiency
NCT00884000 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device
NCT02018172 ·Status: TERMINATED
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children
NCT03290235 ·Status: UNKNOWN ·Phase: PHASE4
-
Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation
NCT01734447 ·Status: COMPLETED ·Phase: PHASE4
-
A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
NCT00840944 ·Status: UNKNOWN ·Phase: PHASE4
-
Growth Retardation In Children With Special Pathological Conditions Or Disease
NCT00163215 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
NCT00174278 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature
NCT01970800 ·Status: WITHDRAWN ·Phase: NA
-
Drug Use Investigation of Somatropin for GHD-ADULTS.
NCT00601419 ·Status: COMPLETED
-
Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
NCT01592500 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Growth Hormone in Children With Growth Hormone Deficiency
NCT00262249 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy
NCT00174291 ·Status: TERMINATED ·Phase: PHASE3
-
The Effect of Growth Hormone in Very Young Girls With Turner Syndrome
NCT00406926 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Response in Girls With Turner Syndrome
NCT01734486 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9
NCT05723835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children
NCT00102817 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
NCT03255694 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
NCT05330325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
NCT04798690 ·Status: RECRUITING
-
Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
NCT00156143 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature
NCT00121875 ·Status: TERMINATED
-
Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy
NCT00625872 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
NCT06709040 ·Status: ENROLLING_BY_INVITATION